Literature DB >> 23370409

Bi-functional properties of Fe3O4@YPO4:Eu hybrid nanoparticles: hyperthermia application.

A I Prasad1, A K Parchur, R R Juluri, N Jadhav, B N Pandey, R S Ningthoujam, R K Vatsa.   

Abstract

Magnetic nanoparticles based hyperthermia therapy is a possible low cost and effective technique for killing cancer tissues in the human body. Fe3O4 and Fe3O4@YPO4:5Eu hybrid magnetic nanoparticles are prepared by co-precipitation method and their average particle sizes are found to be ∼10 and 25 nm, respectively. The particles are spherical, non-agglomerated and highly dispersible in water. The crystallinity of as-prepared YPO4:5Eu sample is more than Fe3O4@YPO4:5Eu hybrid magnetic nanoparticles. The chemical bonds interaction between Fe3O4 and YPO4:5Eu is confirmed through FeO-P. The magnetization of hybrid nanocomposite shows magnetization Ms = 11.1 emu g(-1) with zero coercivity (measured at 2 × 10(-4) Oe) at room temperature indicating superparamagnetic behaviour. They attain hyperthermia temperature (~42 °C) under AC magnetic field showing characteristic induction heating of the prepared nanohybrid and they will be potential material for biological application. Samples produce the red emission peaks at 618 nm and 695 nm, which are in range of biological window. The quantum yield of YPO4:5Eu sample is found to be 12%. Eu(3+) present on surface and core could be distinguished from luminescence decay study. Very high specific absorption rate up to 100 W g(-1) could be achieved. The intracellular uptake of nanocomposites is found in mouse fibrosarcoma (Wehi 164) tumor cells by Prussian blue staining.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23370409     DOI: 10.1039/c2dt32508j

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  1 in total

1.  Emission Enhancement and Energy Transfers in YV0.5P0.5O4 Nanoparticles Codoped with Eu3+ and Bi3+ Ions.

Authors:  Marta Wujczyk; Sara Targonska; Philippe Boutinaud; John M Reeks; Adam Watras; Rafal J Wiglusz
Journal:  Inorg Chem       Date:  2022-07-28       Impact factor: 5.436

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.